The pathogenesis of Parkinson’s disease is closely
linked
to impaired mitochondrial function and abnormal mitophagy. Biocompatible
natural antioxidants effectively protect dopaminergic neurons. However,
the main challenge in using natural antioxidants for Parkinson’s
disease therapy is creating a delivery platform to achieve neuron-targeted
enrichment. Herein, we synthesized rationally sequence-targeted lycopene
nanodots using recombinant human H-ferritin nanocages with lycopene
loading into the cavity and lipophilic triphenylphosphonium (TPP)
coupling on the outer surface. The nanodots allow for the neural enrichment
and mitochondrial regulation of lycopene through blood–brain
barrier transcytosis and neuronal mitochondria-targeting capability.
These anti-ROS nanodots protect neuronal mitochondrial function and
promote PINK1/Parkin-mediated mitophagy in MPTP toxicity-induced neurons in vivo and in vitro, which favors the
secretory efflux of pathogenic α-synuclein and the survival
of dopaminergic neurons. Moreover, these nanodots restore the Parkinson-like
motor symptoms in Parkinson’s model mice. This noninvasive
sequence-targeted delivery strategy with excellent biocompatibility
for pro-survival mitophagy-mediated pathology alleviation makes it
a promising approach for treating and preventing Parkinson’s
disease.